(Q48943157)

17 February 2018

title

Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine (English)

1 reference

17 February 2018

0 references

1

1 reference

17 February 2018

Raffaella Molteni

2

1 reference

17 February 2018

Marco A. Riva

6

1 reference

17 February 2018

author name string

Cecilia Gabriel

3

1 reference

17 February 2018

Elisabeth Mocaer

4

1 reference

17 February 2018

Giorgio Racagni

5

1 reference

17 February 2018

publication date

22 December 2010

1 reference

17 February 2018

published in

Psychopharmacology

1 reference

17 February 2018

volume

215

1 reference

17 February 2018

issue

2

1 reference

17 February 2018

page(s)

267-275

1 reference

17 February 2018

Mouse and rat BDNF gene structure and expression revisited

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

New selective ligands of human cloned melatonin MT1 and MT2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

New approaches to antidepressant drug discovery: beyond monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

BDNF and trkB mRNAs oscillate in rat brain during the light-dark cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Hippocampal changes in patients with a first episode of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Is it time to reassess the BDNF hypothesis of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

At least four distinct circadian regulatory mechanisms are required for all phases of rhythms in mRNA amount

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Circadian rhythm of brain-derived neurotrophic factor in the rat suprachiasmatic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

New insights into BDNF function in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Basal and stress-induced modulation of activity-regulated cytoskeletal associated protein (Arc) in the rat brain following duloxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Could agomelatine be the ideal antidepressant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Effect of agomelatine in the chronic mild stress model of depression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Emerging role of the FGF system in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Untreated Depression and Hippocampal Volume Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

The fibroblast growth factor system and mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Effects of early visual experience and diurnal rhythms on BDNF mRNA and protein levels in the visual system, hippocampus, and cerebellum.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21181122

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neuronal plasticity: a link between stress and mood disorders

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21181122

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21181122

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00213-010-2129-8

1 reference

17 February 2018

1 reference

17 February 2018